Clinical Trial Update: BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating blockade of calcium channels and beta-adrenergic receptors for hypertension in patients with heart failure with preserved ejec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Hypertension

Drugs mentioned

• BLOCKade of Calcium Channels and Beta Adrenergic Receptors

Snippet

Sponsor: University of Pennsylvania | Conditions: Heart Failure With Preserved Ejection Fraction, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2026-01-30